Beam Therapeutics (BEAM): ARK Investment and Cathie Wood report 9.95% stake

Rhea-AI Filing Summary

Beam Therapeutics Inc. is reported as having a significant shareholder. ARK Investment Management LLC and its CEO/CIO Catherine D. Wood report beneficial ownership of 10,234,862 shares of Beam common stock, representing 9.95% of the class as of the reporting date.

ARK has sole voting power over 9,639,107 shares and shared voting power over 151,313 shares, with sole dispositive power over 10,234,862 shares. Catherine D. Wood has shared voting power over 9,790,420 shares and shared dispositive power over 10,234,862 shares. ARK notes that no client currently has more than a 5% interest in these securities except ARK Innovation ETF.

Key Figures

Shares beneficially owned: 10,234,862 shares Percent of class owned: 9.95% ARK sole voting power: 9,639,107 shares +3 more

6 metrics

Shares beneficially owned 10,234,862 shares Beneficially owned by ARK Investment Management LLC and Catherine D. Wood

Percent of class owned 9.95% Percentage of Beam Therapeutics common stock class beneficially owned

ARK sole voting power 9,639,107 shares Shares over which ARK has sole power to vote or direct the vote

ARK shared voting power 151,313 shares Shares over which ARK has shared power to vote or direct the vote

Catherine Wood shared voting power 9,790,420 shares Shares over which Catherine D. Wood has shared voting power

ARK sole dispositive power 10,234,862 shares Shares over which ARK has sole power to dispose or direct disposition

Key Terms

beneficially owned, sole voting power, shared voting power, sole dispositive power, +2 more

6 terms

beneficially owned financial

"Item 4. | Ownership (a) | Amount beneficially owned: ARK and Catherine D. Wood: 10,234,862"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

sole voting power financial

"Number of shares as to which the person has | (i) Sole power to vote or to direct the vote"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

shared voting power financial

"(ii) Shared power to vote or to direct the vote: (i) ARK: 151,313"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

sole dispositive power financial

"(iii) Sole power to dispose or to direct the disposition of: (i) ARK: 10,234,862"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

shared dispositive power financial

"(iv) Shared power to dispose or to direct the disposition of: (ii) Catherine D. Wood: 10,234,862"

Schedule 13G regulatory

"No client of ARK Investment Management LLC currently has an interest in the securities reported herein"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

FAQ

What percentage of Beam Therapeutics (BEAM) shares does ARK Investment Management report owning?

ARK Investment Management LLC and Catherine D. Wood report beneficial ownership of 9.95% of Beam Therapeutics’ common stock, totaling 10,234,862 shares according to the Schedule 13G/A filing.

How many Beam Therapeutics (BEAM) shares are beneficially owned by ARK and Catherine D. Wood?

They report beneficial ownership of 10,234,862 shares of Beam Therapeutics common stock, corresponding to 9.95% of the outstanding class as stated in the ownership section.

What voting power does ARK Investment Management have in Beam Therapeutics (BEAM)?

ARK reports sole voting power over 9,639,107 shares and shared voting power over 151,313 shares of Beam Therapeutics common stock, reflecting its ability to direct voting on those shares.

What is Catherine D. Wood’s reported voting and dispositive power in Beam Therapeutics (BEAM)?

Catherine D. Wood reports shared voting power over 9,790,420 shares and shared dispositive power over 10,234,862 shares of Beam Therapeutics common stock, with no sole voting or dispositive power.

Which ARK client holds more than 5% interest in Beam Therapeutics (BEAM) securities?

The filing states that no ARK client has over 5% interest in the reported Beam securities except ARK Innovation ETF, a series of a Delaware statutory trust, which holds such an interest.

Who are the reporting persons in the Beam Therapeutics (BEAM) Schedule 13G/A?

The reporting persons are ARK Investment Management LLC, organized in Delaware, and Catherine D. Wood, a United States citizen, identified together in the beneficial ownership disclosure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/14/2026 - 02:56 PM Accepted by SEC EDGAR 08/14/2026 - 02:55 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 7)

Beam Therapeutics Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

07373V105

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 07373V105

1

Names of Reporting Persons

ARK Investment Management LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 9,639,107.00
6	Shared Voting Power 151,313.00
7	Sole Dispositive Power 10,234,862.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

10,234,862.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.95 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

CUSIP Number(s): 07373V105

1

Names of Reporting Persons

Catherine D. Wood

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 9,790,420.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 10,234,862.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

10,234,862.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.95 %

12

Type of Reporting Person (See Instructions)

HC, IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Beam Therapeutics Inc.
(b)	Address of issuer's principal executive offices: 238 Main Street, Cambridge, MA 02142
Item 2.
(a)	Name of person filing: (i) ARK Investment Management LLC ("ARK") (ii) Catherine D. Wood
(b)	Address or principal business office or, if none, residence: ARK and Catherine D. Wood: 200 Central Avenue, St. Petersburg, FL 33701
(c)	Citizenship: (i) ARK: Delaware (ii) Catherine D. Wood: United States
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 07373V105
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: ARK and Catherine D. Wood: 10,234,862
(b)	Percent of class: ARK and Catherine D. Wood: 9.95
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: (i) ARK: 9,639,107 (ii) Catherine D. Wood: 0
	(ii) Shared power to vote or to direct the vote: (i) ARK: 151,313 (ii) Catherine D. Wood: 9,790,420
	(iii) Sole power to dispose or to direct the disposition of: (i) ARK: 10,234,862 (ii) Catherine D. Wood: 0
	(iv) Shared power to dispose or to direct the disposition of: (i) ARK: 0 (ii) Catherine D. Wood: 10,234,862
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. No client of ARK Investment Management LLC currently has an interest in the securities reported herein in excess of 5 percent except ARK Innovation ETF, a series of a Delaware statutory trust.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

ARK Investment Management LLC

Signature:	/s/ Kellen Carter
Name/Title:	Kellen Carter, Chief Compliance Officer
Date:	08/14/2026

Catherine D. Wood

Signature:	/s/ Catherine D. Wood
Name/Title:	Catherine D. Wood, Chief Executive Officer, Chief Investment Officer
Date:	08/14/2026